| Literature DB >> 35382262 |
Daniel T Lebre1, Velaphi C Thipe1,2, Marycel E B Cotrim1, José Oscar V Bustillos1.
Abstract
Sugar cane bagasse (SCB) is an abundant byproduct of sugar and bioethanol mills. It has been effectively used as a low-cost biosorbent to remove hazardous chemical compounds from a variety of effluent sources. Herein, we report on the preparation of SCB and its use as a solid phase extraction (SPE) sorbent to retain synthetic hormones (ethinylestradiol, drospirenone, and levonorgestrel) from industrial pharmaceutical plant effluent samples prior to LC-MS/MS quantitative analysis. We evaluated the reproducibility and recoveries and accuracy data analyses were compared with that of commercial SPE (cSPE) cartridges. The results from the evaluated parameters indicated that the SCB bed had an efficiency of >99%, comparable to that of cSPE cartridges, demonstrating the applicability and feasibility of this material as an effective and green chemistry alternative, as well as its biosorbent potential to remove hormones from industrial pharmaceutical effluent.Entities:
Year: 2022 PMID: 35382262 PMCID: PMC8973084 DOI: 10.1021/acsomega.1c06064
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Comparison Results from Different SPE Cartridges (Effluent Industrial Concentration and Accuracya)
| estradiol | ethinylestradiol | levonorgestrel | drospirenone | |||||
|---|---|---|---|---|---|---|---|---|
| SPE cartridges | concn (ng/mL) | accuracy (%) | concn (μg/mL) | accuracy (%) | concn (μg/mL) | accuracy (%) | concn (μg/mL) | accuracy (%) |
| SCB 50 mg | 119 | 120 | 2.43 | 119 | 6.74 | 105 | 65.0 | 99.2 |
| Oasis HLB 30 mg | 99.1 | 100 | 2.04 | 100 | 6.40 | 100 | 65.5 | 100 |
| DCS-18 50 mg | 108 | 109 | 1.67 | 81.9 | 6.16 | 96.3 | 61.3 | 93.6 |
| Envi-Carb 100 mg | N.D. | 0.0 | 0.151 | 7.40 | 1.49 | 23.3 | N.D. | 0.0 |
Accuracy compared with Oasis 30 mg.
Spiked concentration result from 100 ng/mL.
Concentration results from average of n = 6. N.D. = not detected.
Reproducibility (Precision) Results from the Concentration Average of SCB 50 mg SPE of the Synthetic Hormones in Industrial Effluent
| ( | estradiol | ethinylestradiol | levonorgestrel | drospirenone |
|---|---|---|---|---|
| STD | 11.9 | 0.245 | 0.608 | 0.408 |
| CV (%) | 8.65 | 10.1 | 9.03 | 0.628 |
SCB50 mg SPE Cartridges Cycle Use Results in Concentration in Industrial Effluent Sample and Evaluation Recovery from Initial (1x)
| estradiol | ethinylestradiol | levonorgestrel | drospirenone | ||||||
|---|---|---|---|---|---|---|---|---|---|
| SCB 50 mg SPE cartridges | concn (ηg/mL) | recovery (%) | concn (μg/mL) | recovery (%) | concn (μg/mL) | recovery (%) | concn (μg/mL) | recovery (%) | avg recovery (%) |
| 1× | 119 | 100 | 2.43 | 100 | 6.74 | 100 | 65.0 | 100 | 100 |
| 2× | 102 | 85.7 | 2.05 | 84.5 | 5.58 | 82.8 | 62.0 | 95.4 | 87.1 |
| 3× | 103 | 86.6 | 1.85 | 76.3 | 6.58 | 97.7 | 58.0 | 89.3 | 87.4 |
| 4× | 69.9 | 58.7 | 1.23 | 50.7 | 4.62 | 68.6 | 49.0 | 75.4 | 63.4 |
SCB 50 mg SPE Cartridges: Load Concentration (Capacity) in Water
| ethinylestradiol | levonorgestrel | drospirenone | |||||
|---|---|---|---|---|---|---|---|
| nominal concn (μg/mL) | concn (μg/mL) | recovery (%) | concn (μg/mL) | recovery (%) | concn (μg/mL) | recovery (%) | avg recovery (%) |
| 0.05 | 0.047 | 94.2 | 0.054 | 108 | 0.0420 | 108 | 103 |
| 0.125 | 0.103 | 82.4 | 0.1332 | 107 | 0.1034 | 107 | 98.5 |
| 0.250 | 0.201 | 80.4 | 0.232 | 92.8 | 0.212 | 92.8 | 88.7 |
| 0.50 | 0.410 | 82.0 | 0.504 | 101 | 0.478 | 101 | 94.5 |
| 1.00 | 0.805 | 80.5 | 1.04 | 104 | 0.975 | 104 | 96.2 |
| 2.00 | 1.72 | 86.0 | 2.05 | 103 | 2.13 | 103 | 97.0 |
Figure 1SCB 50 mg SPE linear capacity in load concentration in water.
Figure 2Relationship between the breakthrough volume and the SCB 50 mg SPE for the three synthetic hormones (1 μg/mL): ethinylestradiol, levonorgestrel, and drospirenone.
SCB 50 mg SPE Cartridges: pH Difference on Retention Capacity (Fixed Concentration of Synthetic Hormones, 1 μg/mL)
| load condition | ethinylestradiol recovery (%) | levonorgestrel recovery (%) | drospirenone recovery (%) | avg recovery (%) |
|---|---|---|---|---|
| 10 mM HCl pH 1.2 (acid) | 80.0 | 84.0 | 65.9 | 76.6 |
| 10 mM Na2HPO4 pH 7.4 (neutral) | 62.8 | 72.7 | 52.9 | 62.8 |
| 10 mM NH4HCO3 pH 9.4 (basic) | 85.9 | 95.8 | 74.2 | 85.3 |
SCB 50 mg SPE Cartridges: Extraction Solvents Influence on Recovery Data (Fixed Concentration of Synthetic Hormones, 1 μg/mL)
| extraction solvents | estradiol | ethinylestradiol recovery (%) | levonorgestrel recovery (%) | drospirenone recovery (%) | avg recovery (%) |
|---|---|---|---|---|---|
| methanol | 114 | 92.0 | 93.4 | 78.5 | 94.6 |
| acetonitrile | 102 | 99.8 | 99.5 | 80.4 | 95.5 |
| isopropyl alcohol | 104 | 85.7 | 87.7 | 56.0 | 83.4 |
| ethanol | 115 | 103 | 105 | 79.4 | 101 |
| acetone | 132 | 114 | 108 | 94.3 | 112 |
| ethyl acetate | 138 | 111 | 109 | 87.6 | 111 |
| hexane | 0.0 | 0.0 | 9.3 | 0.0 | 2.3 |
Compound control at 100 ηg/mL.
SCB 50 mg SPE Cartridges: Particle Size Variation Evaluation (Fixed Concentration of Synthetic Hormones, 1 μg/mL)
| SCB average particle bed size (μm) | estradiol | ethinylestradiol recovery (%) | levonorgestrel recovery (%) | drospirenone recovery (%) | avg recovery (%) |
|---|---|---|---|---|---|
| 75 | 93.3 | 99.5 | 99.5 | 88.0 | 95.1 |
| 100 | 90.7 | 104 | 104 | 88.5 | 96.6 |
| 187 | 84.3 | 91.8 | 91.8 | 81.8 | 87.4 |
| 303 | 62.9 | 78.6 | 78.6 | 79.0 | 74.8 |
| 390 | 59.2 | 71.4 | 71.4 | 85.7 | 71.9 |
| 567 | 42.2 | 54.1 | 54.1 | 70.6 | 55.2 |
Compound control at 100 ηg/mL.
Results from the Industrial Effluent Samples Using cSPE × SCB
| ethinylestradiol | drosperinone | levonorgestrel | ||||
|---|---|---|---|---|---|---|
| HLB (30 mg) | SCB (50 mg) | HLB (30 mg) | SCB (50 mg) | HLB (30 mg) | SCB (50 mg) | |
| effluent samples | concn mg/L | concn mg/L | concn mg/L | concn mg/L | concn mg/L | concn mg/L |
| Jul/2020 | 1.02 | 1.05 | 29.1 | 29.2 | 2.72 | 2.96 |
| Aug/2020 | 0.691 | 1.01 | 3.81 | 3.20 | 0.878 | 1.02 |
| Sep/2020 | 1.39 | 1.46 | 28.3 | 29.9 | 2.39 | 2.68 |
| Oct/2020 | 1.56 | 1.95 | 5.94 | 6.63 | 3.39 | 3.39 |